Tag: clinical trial
-
ACTG Heralds IPACE-HIV: A Frailty Intervention Study Aims to Improve Physical Ability in People with HIV
ACTG Launches IPACE-HIV to Tackle Frailty in People with HIV The AIDS Clinical Trials Group (ACTG), a global network dedicated to advancing HIV and infectious disease research, announced the opening of a new study focused on frailty interventions in people living with HIV. IPACE-HIV stands for Improving Physical Ability and Cellular Health in HIV, and…
-
Promising HIV Vaccine Candidate Launches Phase 1 Trial
Overview: A New Step in HIV Prevention As the global fight against HIV continues, a new candidate vaccine has moved into Phase 1 clinical testing. The initiation of this trial marks a pivotal moment in preventive science, aiming to determine safety and the ability to elicit an immune response that could eventually reduce new infections.…
-
SU2C Dream Team Targets Early Detection of Gastric Cancer: A Global Push for Prevention
Overview: A Global Mission Against Gastric Cancer Stand Up To Cancer (SU2C) and Cancer Research UK have launched a bold, global effort to halt gastric cancer at its earliest stages. A newly formed dream team brings together leading scientists, clinicians, and patient advocates from multiple countries to accelerate discoveries that could transform prevention, screening, and…
-
SU2C Dream Team Targets Early Detection of Gastric Cancer: Global Clinical Trial on the Horizon
New Frontiers in Gastric Cancer Prevention Stand Up To Cancer (SU2C) and Cancer Research UK (CRUK) have announced a bold new initiative aimed at transforming the fate of gastric cancer through early detection. The newly formed SU2C dream team brings together leading researchers from around the world to accelerate breakthroughs in identifying gastric cancer at…
-
Spider Venom Drug Trial Launches to Fight Heart Attacks and Strokes
Groundbreaking Start for Venom-Derived Therapy In a move that could redefine emergency care for heart disease, researchers in Australia have begun early human trials of a drug derived from the venom of one of the world’s most dangerous spiders. The trial aims to explore a potential treatment for heart attacks and strokes, two leading causes…
-
Spider Venom Drug Trials for Heart Attacks and Strokes
Groundbreaking human trials begin for spider venom-derived drug Researchers in Australia have launched a first-in-human trial of a novel drug derived from the venom of one of the world’s most dangerous spiders. The Phase 1 study aims to evaluate safety, tolerability, and preliminary signals of efficacy for a treatment that could transform responses to heart…
-
Backed Vaccination Study Begins in Guinea: Delaying Hepatitis B for Newborns
Overview of the Trial A new, government-funded clinical study began this week in Guinea-Bissau, focused on the timing of hepatitis B vaccination for newborns. The project, supported by funding from the United States Centers for Disease Control and Prevention (CDC), aims to delay the initial hepatitis B vaccine dose for some infants so researchers can…
-
Guinea-Bissau Hepatitis B Vaccination Timing Study Begins
Overview of the Guinea-Bissau Vaccination Timing Study A US government-funded study has begun in Guinea-Bissau to examine whether delaying the first hepatitis B vaccination for newborns could influence health outcomes. The trial, which involves up to 7,000 newborns, seeks to compare different vaccination timing strategies and assess any differences in infection rates, immune response, and…
-
Oral Wegovy Pill Expands Across the US: Broad Availability and Weight-Loss Potential
Overview: Wegovy enters a new era as an oral GLP-1 option The obesity treatment landscape is changing again as Novo Nordisk’s Wegovy® becomes broadly available in an oral tablet form for adults in the United States. This marks the first and only oral glucagon-like peptide-1 (GLP-1) receptor agonist approved for weight management, offering a convenient…
-
Treating Head and Neck Squamous Cell Carcinoma with Intratumoral Bacteria: New Hope from Radiation and Chemotherapy Advances
Understanding the Breakthrough Head and neck squamous cell carcinoma (HNSCC) is a challenging cancer type, often requiring aggressive radiation and chemotherapy regimens. Recent research, including an international multicenter trial led by MSK radiation oncologist Dr. Nancy Lee, has explored a provocative idea: bacteria residing inside tumors can impact how cancer responds to standard treatments. This…